Evidence map›Paper›PMID 27478693›Full record

ArticlePeerJ2016

New insight into the role of MMP14 in metabolic balance.

Hidetoshi Mori, Ramray Bhat, Alexandre Bruni-Cardoso, Emily I Chen, Danielle M Jorgens, Kester Coutinho, Katherine Louie, Benjamin Ben Bowen, Jamie L Inman, Victoria Tecca and 7 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  11. Article
  12. Article
  13. The Expanding Role of MT1-MMP in Cancer Progression.Pharmaceuticals (Basel, Switzerland) · 2019
    Review
  14. Review
  15. Pathobiology of the 129:Stat1Breast cancer research : BCR · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 4 countries.

Hidetoshi MoriDepartment of Pathology, Center for Comparative Medicine, University of California,Davis,CA,USA; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory,Berkeley,CA,USA.
Ramray BhatBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory,Berkeley,CA,USA; Calcutta Medical College, University of Calcutta, Calcutta, India.
Alexandre Bruni-CardosoBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory,Berkeley,CA,USA; Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo,São Paulo,Brazil.
Emily I ChenDepartment of Pharmacology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center , New York , NY , USA.
Danielle M JorgensMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Kester CoutinhoMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Katherine LouieEnvironmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Benjamin Ben BowenEnvironmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Jamie L InmanBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Victoria TeccaBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Sarah J LeeBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Sabine Becker-WeimannBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Trent NorthenEnvironmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Motoharu SeikiInstitute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Alexander D BorowskyDepartment of Pathology, Center for Comparative Medicine, University of California, Davis, CA, USA.
Manfred AuerMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Mina J BissellBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Lawrence Berkeley National Laboratory · USColumbia University Irving Medical Center · USKanazawa University · JPUniversity of California, Davis · US

Funding

Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI MILLS, GORDON B. · 2004 to 2014
$27.1M
Role of Metalloproteinases in Mammary Gland RemodelingR01CA057621 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 1993 to 2017
$9.0M
Definition of the Microenvironment in Breast CancerR01CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 1995 to 2020
$6.1M
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)U01CA143233 · NCI · DANA-FARBER CANCER INST · PI BISSELL, MINA, POLLARD, JEFFREY W. · 2009 to 2013
$2.5M
High Content Representation and Association of 3D Cell Culture ModelsR01CA140663 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PARVIN, BAHRAM A. · 2011 to 2014
$2.4M
Definition of Microenvironment in Breast CancerR37CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2009 to 2013
$2.0M
Acquisition of an Applied Biosystems 4000 QTRAP Mass SpectrometerS10RR023680 · NCRR · STATE UNIVERSITY NEW YORK STONY BROOK · PI IDEN, CHARLES R · 2007 to 2007
$435k
NCI NIH HHS R01 CA057621NCI NIH HHS R01 CA064786NCI NIH HHS R01 CA140663NCI NIH HHS R37 CA064786NCI NIH HHS U01 CA143233NCI NIH HHS U54 CA112970NCRR NIH HHS S10 RR023680
6 · The paper itself

Abstract

Membrane-anchored matrix metalloproteinase 14 (MMP14) is involved broadly in organ development through both its proteolytic and signal-transducing functions. Knockout of Mmp14 (KO) in mice results in a dramatic reduction of body size and wasting followed by premature death, the mechanism of which is poorly understood. Since the mammary gland develops after birth and is thus dependent for its functional progression on systemic and local cues, we chose it as an organ model for understanding why KO mice fail to thrive. A global analysis of the mammary glands' proteome in the wild type (WT) and KO mice provided insight into an unexpected role of MMP14 in maintaining metabolism and homeostasis. We performed mass spectrometry and quantitative proteomics to determine the protein signatures of mammary glands from 7 to 11 days old WT and KO mice and found that KO rudiments had a significantly higher level of rate-limiting enzymes involved in catabolic pathways. Glycogen and lipid levels in KO rudiments were reduced, and the circulating levels of triglycerides and glucose were lower. Analysis of the ultrastructure of mammary glands imaged by electron microscopy revealed a significant increase in autophagy signatures in KO mice. Finally, Mmp14 silenced mammary epithelial cells displayed enhanced autophagy. Applied to a systemic level, these findings indicate that MMP14 is a crucial regulator of tissue homeostasis. If operative on a systemic level, these findings could explain how Mmp14KO litter fail to thrive due to disorder in metabolism.

Indexed as

AutophagyEnergy metabolismGlucoseGlycogenHomeostasisLipidsMammary glandMatrix metalloproteinase 14Mmp14KO mouseTriglycerides

Identifiers

PMID27478693
PMCPMC4950575
OpenAlexW2466256114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.